Vaccitech is an Oxford, U.K.-based biotech startup developing vaccines and immunotherapies for infectious diseases and cancer, such as hepatitis B, HPV, and prostate cancer. Vaccitech owns the technology used to develop the AstraZeneca COVID-19 vaccine. A spinout of Oxford University, Vaccitech […]
The post Vaccitech, the biotech startup behind AstraZeneca COVID-19 vaccine developed using an altered form of chimpanzee cold virus, tumbles 20% in Nasdaq IPO debut appeared first on Tech News | Startups News.
12 total views